DISCLAIMER
Today’s presentation will include the use of Botulinum Toxin A in the FDA approved Glabellar, Crow’s Feet, and Forehead areas (on a botulinum toxin A)
In addition, areas of the upper face that are not included in the FDA indication will be shared.
These injections are considered off-label use and within accepted and published standards.
